-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Cumberland Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Cumberland Pharmaceuticals Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.69M, a 9.22% increase year-over-year.
- Cumberland Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$10.8M, a 90.5% decline year-over-year.
- Cumberland Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$9.55M, a 67.5% decline from 2022.
- Cumberland Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$5.7M, a 25.7% increase from 2021.
- Cumberland Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$7.68M, a 20.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)